1887

Health at a Glance 2013

OECD Indicators

image of Health at a Glance 2013

This seventh edition of Health at a Glance provides the latest comparable data on different aspects of the performance of health systems in OECD countries. It provides striking evidence of large variations across countries in health costs, health activities and health results of health systems. Key health indicators provide information on health status including suicide and life expectancy, the determinants of health, health care activities and health expenditure and financing in OECD countries. Each health indicator in the book is presented in a user-friendly format, consisting of charts illustrating variations across countries and over time, brief descriptive analyses highlighting the major findings conveyed by the health data, and a methodological box on the definition of the indicator and any limitations in data comparability.

English French, Korean

.

Pharmaceutical generic market share

All OECD countries see the development of generic markets as a good opportunity to increase efficiency in pharmaceutical spending, by offering cheaper products than on-p-atent drugs for an equivalent health outcome. However, in 2011, generics accounted for about three-quarter of the volume of pharmaceuticals covered by basic health coverage in Germany, the United Kingdom, New Zealand and D-enmark, while they represented less than one-quarter of the market in Luxembourg, Italy, Ireland, Switzerland, Japan and France ().

English French

Graphs

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error